Literature DB >> 1660803

[Heparin-associated thrombocytopenia, thrombosis and embolism. Side effects of thromboembolism prevention with low molecular weight heparin enoxaparin?].

V D Mohr1, J Lenz.   

Abstract

Heparin-associated thrombocytopenia (HAT) is a rarely described adverse reaction of systemic administration of heparin that may be complicated by thrombosis, embolism and bleeding. Unfractionated heparin as well as low molecular weight heparin may provoke HAT. A case of HAT complicated by thrombosis and pulmonary embolism is described that came about during preventive postoperative anticoagulation with the low molecular weight heparin enoxaparin. Pathogenesis, diagnosis, prophylaxis and therapy of HAT are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660803

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  4 in total

1.  [Implementing ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity].

Authors:  H J Kock; K P Schmit-Neuerburg; J Hanke; A Terwort; G Rudofsky; H Hirche
Journal:  Unfallchirurgie       Date:  1994-12

2.  Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparin.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

Review 3.  Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders.

Authors:  J E Frampton; D Faulds
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

Review 4.  Clinical use of parnaparin in major and minor orthopedic surgery: a review.

Authors:  Stefano Bugamelli; Elena Zangheri; Milena Montebugnoli; Lucia Guerra
Journal:  Vasc Health Risk Manag       Date:  2008
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.